At UW Urology, we’re advancing care through research to better predict recurrence and personalize treatment for patients with RCC – moving kidney cancer care beyond one-size-fits-all. urology.wisc.edu/.../advancin... @ddshapiro.bsky.social @ejasonabel.bsky.social #KidneyCancerAwarenessMonth

Winship urologist Vikram Narayan, MD, FACS, was profiled by Apple for Emory Healthcare's use of Apple technology to streamline workflows and enhance patient care. 🎥 Read more and Watch the video ➡️ brnw.ch/21wUcrF

Cancer cells leverage epithelial-to-mesenchymal transition (EMT) to promote treatment resistance and metastasis. Results from a recent MD Anderson study found that EMT is a necessary step for pancreatic tumors to become malignant. Learn more: brnw.ch/21wR9Zv #EndCancer

Study offers insights into evolutionary process driving pancreatic cancer aggressiveness

brnw.ch

A whole generation of early career scientists and physician-scientists, including colleagues and myself, are particularly vulnerable to these funding freezes and cuts, with jobs and careers depending on federal grants. #IDsky #Medsky #Episky www.science.org/content/arti...

U.S. early-career researchers struggling amid chaos

Uncertain funding, government firings, and distressed universities hit vulnerable groups especially hard

science.org

Final day of #GU25! Kicking things off with Oral Abstract Session C: Renal Cell Cancer—looking forward to the latest insights and discussions.

It’s nearly impossible to describe how severe a cut this is for universities. And all through executive action. The university lobbyists, that they relied on to recruit bipartisan support in Congress for so long, have no traction here. Key text:

1/ That "immortal time" is so frequent in survival analyses for #causalinference is fascinating. Because "immortal time" doesn't exist in the data, *we* create it when misanalyzing the data. Our new paper pubmed.ncbi.nlm.nih.gov/39494894/ summarizes why immortal time arises & how to prevent it.

Thx again to my friend @ddshapiro.bsky.social for giving us an outstanding Grand Rounds today @emoryuroonc.bsky.social & @winshipatemory.bsky.social on #RenalMedullaryCarcinoma. Inspiring work presented in an incredibly understandable & engaging way @msaouel.bsky.social @jackiebrownmd.bsky.social

85 people in here now, and growing - come and join us! #Genitourinary #Oncology #GUonc #GUoncol #GUoncology #ProstateCancer #KidneyCancer #Urothelial #BladderCancer #PenileCancer #TesticularCancer #pcsm #kcsm #blcsm #tcsm #Medsky #Oncsky #Medtwitter go.bsky.app/DtoXvaD

And let me know if you want to be included.

@ejasonabel.bsky.social discussing complex RCC cases at #suo. @wiscurology.bsky.social

Badgers representing at #SUO24! @ddshapiro.bsky.social @ejasonabel.bsky.social #UrologicOncology

Proud of our first @emoryuroonc.bsky.social SUO fellow #TaylorGoodstein making a splash in RCC research at the #SUO24 Winter Meeting @ssjoshi.bsky.social @jackiebrownmd.bsky.social

Proud of my friend @drnarayan.com giving great talk at #suo on cystectomy for NMIBC

Very interesting paper on confidence interval theory and misconceptions #StatsSky #Statistics

Richard McElreath 🐈‍⬛@rmcelreath.bsky.social · 2y ago

Prob this one doi.org/10.3758/s134...

Made this with @ddshapiro.bsky.social, reach out if we missed you! @mdanderson.bsky.social @chapinmd.bsky.social go.bsky.app/NwN3jSo

Proud of the UW med students presenting their summer kidney cancer research projects @uwmadison.bsky.social

@emoryuroonc.bsky.social welcome to Bluesky!

A starter pack for people living, working, treating, studying kidney cancer #kidneycancer #kcsm #renalcellcarcinoma #RCC, please share and suggest go.bsky.app/JGYhGhd

Welcome to @bsky.app my friend @ddshapiro.bsky.social Time to get him added to the GU onc and kidney cancer starter packs!! bsky.app/start/did:pl...